重庆医学
重慶醫學
중경의학
CHONGQING MEDICAL JOURNAL
2013年
22期
2571-2573
,共3页
兰天%常秀亭%勾红菊%吴腾%王丽京%黄河清
蘭天%常秀亭%勾紅菊%吳騰%王麗京%黃河清
란천%상수정%구홍국%오등%왕려경%황하청
SphK1-S1P信号通路%纤维连接蛋白%糖尿病肾病%STZ
SphK1-S1P信號通路%纖維連接蛋白%糖尿病腎病%STZ
SphK1-S1P신호통로%섬유련접단백%당뇨병신병%STZ
SphK1-S1P signaling pathway%fibronectin%diabetic nephropathy%STZ
目的观察鞘氨醇激酶1-1-磷酸鞘氨醇(SphK1-S1P)信号通路在链脲佐菌素(STZ)诱导的糖尿病大鼠肾脏中的激活情况。方法观察 STZ诱导的糖尿病大鼠肾脏中 SphK1-S1P信号通路的激活情况。分别检测大鼠肾脏功能及病理指标。采用液质联用分析 SphK1活性及 S1P含量。并采用免疫组织化学、Real-time PCR和 Western blot法检测了 SphK1的表达。结果STZ诱导的糖尿病大鼠血糖、肾重体质量比、24 h尿蛋白显著升高,糖尿病大鼠肾脏系膜区肥大,细胞外基质扩展。同时,糖尿病大鼠肾脏中 SphK1-S1P信号通路被激活,表现为 SphK1表达和活性增加,以及 S1P 生成增加。结论糖尿病大鼠肾脏中存在SphK1-S1P信号通路的激活,可能参与了糖尿病大鼠肾损伤过程。
目的觀察鞘氨醇激酶1-1-燐痠鞘氨醇(SphK1-S1P)信號通路在鏈脲佐菌素(STZ)誘導的糖尿病大鼠腎髒中的激活情況。方法觀察 STZ誘導的糖尿病大鼠腎髒中 SphK1-S1P信號通路的激活情況。分彆檢測大鼠腎髒功能及病理指標。採用液質聯用分析 SphK1活性及 S1P含量。併採用免疫組織化學、Real-time PCR和 Western blot法檢測瞭 SphK1的錶達。結果STZ誘導的糖尿病大鼠血糖、腎重體質量比、24 h尿蛋白顯著升高,糖尿病大鼠腎髒繫膜區肥大,細胞外基質擴展。同時,糖尿病大鼠腎髒中 SphK1-S1P信號通路被激活,錶現為 SphK1錶達和活性增加,以及 S1P 生成增加。結論糖尿病大鼠腎髒中存在SphK1-S1P信號通路的激活,可能參與瞭糖尿病大鼠腎損傷過程。
목적관찰초안순격매1-1-린산초안순(SphK1-S1P)신호통로재련뇨좌균소(STZ)유도적당뇨병대서신장중적격활정황。방법관찰 STZ유도적당뇨병대서신장중 SphK1-S1P신호통로적격활정황。분별검측대서신장공능급병리지표。채용액질련용분석 SphK1활성급 S1P함량。병채용면역조직화학、Real-time PCR화 Western blot법검측료 SphK1적표체。결과STZ유도적당뇨병대서혈당、신중체질량비、24 h뇨단백현저승고,당뇨병대서신장계막구비대,세포외기질확전。동시,당뇨병대서신장중 SphK1-S1P신호통로피격활,표현위 SphK1표체화활성증가,이급 S1P 생성증가。결론당뇨병대서신장중존재SphK1-S1P신호통로적격활,가능삼여료당뇨병대서신손상과정。
Objective We aimed to investigate whether SphK1-S1P signaling pathway is activated in diabetic nephropathy.Meth-ods SphK1 activity and S1P levels were measured by LC-MS/MS analysis.The expression of SphK1 were examined by immuno-histochemistry,real-time PCR and Western blot.Results Fasting blood glucose,kidney/body weight ratio and 24-h albuminuria were significantly increased in diabetic mice.Furthermore,mesangial hypertrophy was found in diabetic kidney.Strikingly,the stai-ning,activity and levels of mRNA and protein of SphK1,and S1P production in diabetic kidney were also markedly increased in dia-betic mouse kidney.Conclusion These results demonstrate that the SphK1-S1P signaling pathway is activated in diabetic kidney, suggesting that SphK1-S1P signaling pathway is implicated in the pathogenesis of diabetic nephropathy.